文献
J-GLOBAL ID:202202265410994054
整理番号:22A0576926
ERBB2の高発現はステージT1非筋肉浸潤性膀胱癌患者における無再発生存低下の独立危険因子である【JST・京大機械翻訳】
High expression of ERBB2 is an independent risk factor for reduced recurrence-free survival in patients with stage T1 non-muscle-invasive bladder cancer
著者 (24件):
Sikic Danijel
(Department of Urology and Pediatric Urology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany)
,
Sikic Danijel
(Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany)
,
Eckstein Markus
(Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany)
,
Eckstein Markus
(Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany)
,
Weyerer Veronika
(Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany)
,
Weyerer Veronika
(Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany)
,
Kubon Jennifer
(Department of Urology and Pediatric Urology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany)
,
Kubon Jennifer
(Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany)
,
Breyer Johannes
(Department of Urology, University of Regensburg, Caritas St. Josef Medical Center, Regensburg, Germany)
,
Roghmann Florian
(Department of Urology, Marien Hospital Herne, Ruhr University Bochum, Herne, Germany)
,
Kunath Frank
(Department of Urology and Pediatric Urology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany)
,
Kunath Frank
(Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany)
,
Keck Bastian
(Department of Urology and Pediatric Urology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany)
,
Keck Bastian
(Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany)
,
Erben Philipp
(Department of Urology, University Medical Centre Mannheim, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany)
,
Hartmann Arndt
(Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany)
,
Hartmann Arndt
(Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany)
,
Wirtz Ralph M.
(STRATIFYER Molecular Pathology GmbH, Cologne, Germany)
,
Wullich Bernd
(Department of Urology and Pediatric Urology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany)
,
Wullich Bernd
(Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany)
,
Taubert Helge
(Department of Urology and Pediatric Urology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany)
,
Taubert Helge
(Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany)
,
Wach Sven
(Department of Urology and Pediatric Urology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany)
,
Wach Sven
(Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany)
資料名:
Urologic Oncology: Seminars and Original Investigations
(Urologic Oncology: Seminars and Original Investigations)
巻:
40
号:
2
ページ:
63.e9-63.e18
発行年:
2022年
JST資料番号:
W3220A
ISSN:
1078-1439
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)